US › Healthcare

Alector Inc (ALEC)

US · Healthcare · Biotechnology

$1.85-3.90%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$3.3M

Revenue YoY

-57.8%

Net profit

$-23.0M

EPS

$-0.21

EPS estimate

$-0.24

Net margin

-692.5%

EPS came in at -0.21 against a street estimate of -0.24 — a beat of 12.5%.

Key statistics

Market cap

$214.9M

Forward P/E

8.5

P/B

19.57

Book value

$-0.09

EPS (TTM)

$-1.03

52-week high

$3.40

52-week low

$1.09

50-day MA

$1.93

200-day MA

$1.95

Beta

0.65

Analyst view

Analysts rate Alector Inc a buy (6 buy, 1 hold, 2 sell out of 9) with an average price target of $3.10.

Shareholding

Insiders

9.61%

Institutions

84.91%

Largest institutional holders

Fund	Stake
TCG Crossover Management, LLC	8.96%
BlackRock Inc	6.93%
Acadian Asset Management LLC	3.62%
Kynam Capital Management, LP	3.41%
Vanguard Capital Management, LLC	3.29%
Merck & Co Inc	3.18%
683 Capital Management LLC	2.87%
D. E. Shaw & Co LP	2.65%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alector Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.